[EN] ENZYME INHIBITORS AND THE USE THEREOF<br/>[FR] INHIBITEURS D'ENZYME ET UTILISATION DE CEUX-CI
申请人:DARA BIOSCIENCES INC
公开号:WO2010008473A1
公开(公告)日:2010-01-21
The present invention provides compounds and methods for the treatment of diseases or disorders such as heart failure, hyperlipidemia, hypercholesterolemia, gonadotropin deficiency, diabetes mellitus, metabolic syndrome, hyperglycemia, insulin resistance, glucose intolerance, obesity, psoriasis, atopic dermatitis, and cancer.
Scarborough; Waters, Journal of the Chemical Society, 1927, p. 1136
作者:Scarborough、Waters
DOI:——
日期:——
Wanag, Latvijas universitates raksti. Kimijas fakultates serija, 1938, vol. 4, p. 405,417
作者:Wanag
DOI:——
日期:——
Preparation of N-substituted phthalimides by the palladium-catalyzed carbonylation and coupling of o-dihalo aromatics and primary amines
作者:Robert J. Perry、S. Richard Turner
DOI:10.1021/jo00023a023
日期:1991.11
A novel method for the formation of N-substituted phthalimides is described which is based on the palladium-catalyzed carbonylation and coupling of o-dihalo aromatics and primary amines. Optimal conditions established for the reaction using o-diiodobenzene and aniline were DMAc (0.2 M), 115-degrees-C, 90 psi of CO, 3% PdCl2L2, and 2.4 equiv of DBU. This process is tolerant of a wide variety of functional groups and gives good yields of the desired products. Variables such as temperature, catalyst type and loading, CO pressure, solvent, and base were examined to optimize this reaction. The reaction of aniline with 1,2-dibromocyclopentene under similar conditions gave a variety of products.